We are live on ! Find out more
BIOTU

Biotech Acquisition Company Unit
BIOTU

Delisted

BIOTU was delisted on the 2nd of February, 2023.

Back to rankings

10 hedge funds and large institutions have $2.96M invested in Biotech Acquisition Company Unit in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 15 → 10 (-5)

43% less capital invested

Capital invested by funds: $5.18M → $2.96M (-$2.22M)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
10
Holders Change
-5
Holders Change %
-33.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$126K
2
WAM
Wolverine Asset Management
Illinois
+$10.3K
3
UBS Group
UBS Group
Switzerland
+$1.87K

Top Sellers

Rank Fund Capital Flow
1
SMA
Sage Mountain Advisors
Georgia
-$510K
2
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$508K
3
WC
Wealthspring Capital
New York
-$461K
4
SIA
Schechter Investment Advisors
Michigan
-$346K
5
BCM
BCK Capital Management
Connecticut
-$275K
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
1
HRT Financial
New York
$889K – – –
WCMNY
2
Westchester Capital Management (New York)
New York
$494K – – –
Millennium Management
3
Millennium Management
New York
$446K – – –
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$413K – – –
Walleye Capital
5
Walleye Capital
New York
$369K +$126K +12,593 +51%
LCM
6
Landscape Capital Management
New Jersey
$218K – – –
Morgan Stanley
7
Morgan Stanley
New York
$83K – – –
SIA
8
SkyView Investment Advisors
New Jersey
$31K – – –
WAM
9
Wolverine Asset Management
Illinois
$10K +$10.3K +1,028 New
UBS Group
10
UBS Group
Switzerland
$7K +$1.87K +187 +38%
SMA
11
Sage Mountain Advisors
Georgia
– -$510K -50,900 Closed
COPPSERS
12
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$508K -50,000 Closed
WC
13
Wealthspring Capital
New York
– -$461K -45,935 Closed
SIA
14
Schechter Investment Advisors
Michigan
– -$346K -34,525 Closed
BCM
15
BCK Capital Management
Connecticut
– -$275K -27,146 Closed
OCAM
16
Owl Creek Asset Management
New York
– -$202K -20,000 Closed

BIOTU Hedge Fund Activity: Q1 2022 in Review

10 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Unit (BIOTU) for Q1 2022, worth a combined $2.96M — down 43% from $5.18M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BIOTU and 1 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Walleye Capital, adding an estimated $126K. The largest seller was Sage Mountain Advisors, exiting entirely with an estimated $510K sold.

  • 10 institutional investors held Biotech Acquisition Company Unit (BIOTU) as of Q1 2022, down from 15 in Q4 2021.
  • Funds reported $2.96M of Biotech Acquisition Company Unit stock for Q1 2022, down 43% quarter-over-quarter.
  • 1 fund opened new Biotech Acquisition Company Unit positions in Q1 2022 and 6 closed out, a net change of -5 holders.
  • The largest Biotech Acquisition Company Unit buyer in Q1 2022 was Walleye Capital, an estimated $126K added.
  • The largest Biotech Acquisition Company Unit seller in Q1 2022 was Sage Mountain Advisors, an estimated $510K sold.

Based on aggregated 13F filings for Q1 2022.